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See Article, pages 830–836The liver is considered to be an organ with unusual immune
functions promoting immune tolerance rather than immunity
[1,2]. This unique immune feature is believed to contribute to
spontaneous acceptance of orthotopic liver grafts and may impair
the capability of the immune system to clear liver infections by
hepatotropic viruses, thereby promoting viral persistence and
chronic hepatitis. Key to the understanding of liver immunology
are the tolerogenic hepatic microenvironment and the local hepa-
tic antigen presenting cells (APC) that have particular features
and contribute to hepatic immune regulation through local prim-
ing of CD8+ T cells.
Hepatic APC cells comprise truly liver-resident cell popula-
tions such as hepatocytes but also bone marrow-derived APC
such as Kupffer cells or liver dendritic cells. Antigen presentation
by liver-resident hepatocytes to naïve CD8+ T cells can lead to
hepatocyte-mediated T cell elimination through a process called
suicidal emperipolesis, where naïve T cells entering hepatocytes
are degraded [3]. Alternatively, incomplete activation of naïve
CD8+ T cells has been shown to lead to over-expression of pro-
apoptotic molecules, such as the BH3-only protein Bim, that
mediates apoptosis in hepatocyte-primed T cells [4]. Bone-mar-
row derived professional APC, such as dendritic cells, are compro-
mised in their ability to elicit adaptive immunity when they
lodge in the liver [5–7]. The T cell-intrinsic mechanisms that
determine the lack of T cell immunity after local priming by
hepatic antigen-presenting cells, however, have not been exhaus-
tively addressed.
The article by Holz et al. in this issue of the Journal of Hepatol-
ogy [8] sheds new light on the important question of how the
liver microenvironment changes the ability of bone marrow-
derived APC to prime naive CD8 T cells. Using the well-deﬁned
experimental system of DES-TCR transgenic T cells, recognizing
an endogenous peptide in the context of the MHC class I molecule
H-2Kb, Holz et al. demonstrate that in bone marrow chimeric
mice hepatic bone marrow-derived APC present antigen in an
MHC class I – restricted fashion locally in the liver to circulating
naïve CD8 T cells. Whereas naïve T cell priming by antigen-pre-
senting hepatocytes leads to a particular T cell phenotype,
characterized by low expression levels of CD25/CD54
and high expression of the pro-apoptotic molecule Bim
(CD25lowCD54lowBimhi), T cell priming by professional boneJournal of Hepatology 20
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CD25hiCD54hiBimlow phenotype [9]. The high expression levels
of the pro-apoptotic molecule Bim in T cells following their
priming by antigen-presenting hepatocytes correlates with
subsequent T cell death and peripheral tolerance [4]. Holz et al.
report in this issue of the Journal of Hepatology that naïve CD8+
T cell priming by bone marrow-derived APC in the liver leads
to a T cell phenotype (CD25hiCD54hiBimhi) that is distinct from
that induced by antigen-presenting hepatocytes or by bone
marrow-derived antigen-presenting cells in the lymph node.
However, these T cells similarly to hepatocyte-primed T cells
show increased Bim-dependent apoptosis [8], which reveals the
dominance of the liver as immune regulatory organ over the
capability of bone marrow-derived APC to elicit T cell immunity.
The molecular mechanisms determining the development of
this pro-apoptotic state in liver-primed T cells remain generally
unclear. It is possible that increased expression levels of co-inhib-
itory molecules on hepatic bone marrow-derived APC [6,7,10],
which are known to impair delivery of co-stimulatory molecules
to T cells, elicit the high expression levels of Bim. However, the
expression levels of Bim alone in T cells are not predictive of sub-
sequent T cell death, because also central memory T cells, that
survive over long periods of time, have been shown to express
high levels of Bim [11]. It has been shown that other factors deter-
mine whether liver-primed T cells become sensitive to Bim-
dependent apoptosis. Expression of the anti-apoptotic molecule
Bcl2 functionally antagonizes Bim and promotes survival. T cells
primed by hepatocytes or bone marrow-derived APC in the liver
have essentially unchanged Bcl2 expression levels [8] that are
not sufﬁcient to antagonize the increased levels of Bim. Moreover,
it was found that IL-7 signaling regulates the pro-apoptotic activ-
ity of Bim in peripheral T cell survival also at the posttranslational
level [12]. It is of interest to note that hepatocytes express IL-7
during inﬂammation and thereby locally inﬂuence the quality of
local T cell responses in the liver [13]. These ﬁndings indicate that
local antigen-presentation in the liver does not lead to develop-
ment of T cell survival and immunity under steady-state non-
inﬂammatory conditions but requires hepatocyte-derived signals
that are generated during liver inﬂammation.
Interestingly, high expression levels of Bim were also found in
HBV-speciﬁc CD8+ T cells in patients suffering from chronic hep-
atitis B [14]. It is suspected that Bim-mediated deletion of virus-
speciﬁc CD8 T cells contributes to the inability of these patients
to control HBV infection. It is not possible, however, to conclude12 vol. 57 j 718–719
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from the study by Holz et al. in this issue of the Journal of Hepa-
tology that elevated levels of Bim in HBV-speciﬁc CD8+ T cells
resulted from intrahepatic T cell priming by bone marrow-
derived APC. Cross-presentation is required for potent anti-viral
CD8+ T cell immunity [15], but the experimental system used
by Holz et al. precludes the study of cross-presentation of exoge-
nous antigens on MHC class I molecules. Moreover, elevated lev-
els of Bim were also found in CD8 T cells undergoing peripheral
deletion following cross-presentation of auto-antigens from pan-
creatic islets [16]. Therefore, Bim-dependent T cell death to
restrict T cell immunity is not a mechanism that is selectively
observed following antigen presentation in the liver.
Furthermore, not all APC populations in the liver induce high
levels of Bim in T cells upon local priming in the liver. Another
liver-resident cell populations, i.e. liver sinusoidal endothelial
cells, also prime naïve CD8+ T cells but do not induce clonal T cell
deletion [17,18] or high levels of Bim in T cells (Böttcher and
Knolle, unpublished observation) but still induce a non-respon-
sive state towards further stimulation through the T cell receptor.
CD8 T cell survival and functionality is critical for development of
efﬁcient immunity. Therefore, more research is required to better
understand the cell-intrinsic molecular mechanisms of T cell pro-
gramming following local liver priming by hepatic APC because
these events contribute to the pathogenesis of clinically relevant
disease such as rejection of liver transplants and chronic viral
infection.Conﬂict of interest
The author declared that he does not have anything to disclose
regarding funding or conﬂict of interest with respect to this
manuscript.
References
[1] Thomson AW, Knolle PA. Antigen-presenting cell function in the tolerogenic
liver environment. Nat Rev Immunol 2010;10:753–766.
[2] Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol 2009;27:
147–163.
[3] Benseler V, Warren A, Vo M, Holz LE, Tay SS, Le Couteur DG, et al. Hepatocyte
entry leads to degradation of autoreactive CD8 T cells. Proc Natl Acad Sci USA
2011;108:16735–16740.Journal of Hepatology 201[4] Holz LE, Benseler V, Bowen DG, Bouillet P, Strasser A, O’Reilly L, et al.
Intrahepatic murine CD8 T-cell activation associates with a distinct
phenotype leading to Bim-dependent death. Gastroenterology 2008;135:
989–997.
[5] De Creus A, Abe M, Lau AH, Hackstein H, Raimondi G, Thomson AW. Low
TLR4 expression by liver dendritic cells correlates with reduced capacity to
activate allogeneic T cells in response to endotoxin. J Immunol
2005;174:2037–2045.
[6] Castellaneta A, Sumpter TL, Chen L, Tokita D, Thomson AW. NOD2 ligation
subverts IFN-alpha production by liver plasmacytoid dendritic cells and
inhibits their T cell allostimulatory activity via B7-H1 up-regulation. J
Immunol 2009;183:6922–6932.
[7] Matta BM, Raimondi G, Rosborough BR, Sumpter TL, Thomson AW. IL-27
production and STAT3-dependent upregulation of B7-H1 mediate immune
regulatory functions of liver plasmacytoid dendritic cells. J Immunol
2012;188:5227–5237.
[8] Holz LE, Benseler V, Vo M, McGuffog C, Van Rooijen N, McCaughan GW, et al.
Naive CD8 T cells activation by liver bone marrow-derived cells leads to a
‘‘neglected’’ IL-2(low) Bim(high) phenotype, poor CTL function and cell
death. J Hepatol 2012;57:830–836.
[9] Bowen DG, Zen M, Holz L, Davis T, McCaughan GW, Bertolino P. The site of
primary T cell activation is a determinant of the balance between intrahe-
patic tolerance and immunity. J Clin Invest 2004;114:701–712.
[10] Jung K, Kang M, Park C, Choi YH, Jeon Y, Park SH, et al. The protective role of
VSIG4 expressed on kupffer cells during immune-mediated liver injury by
inducing tolerance of liver T- and NKT-cells. Hepatology, in press. http://
dx.doi.org/10.1002/hep.25906.
[11] Kurtulus S, Tripathi P, Moreno-Fernandez ME, Sholl A, Katz JD, Grimes HL,
et al. Bcl-2 allows effector and memory CD8+ T cells to tolerate higher
expression of Bim. J Immunol 2011;186:5729–5737.
[12] Li WQ, Guszczynski T, Hixon JA, Durum SK. Interleukin-7 regulates Bim
proapoptotic activity in peripheral T-cell survival. Mol Cell Biol
2010;30:590–600.
[13] Sawa Y, Arima Y, Ogura H, Kitabayashi C, Jiang JJ, Fukushima T, et al. Hepatic
interleukin-7 expression regulates T cell responses. Immunity 2009;30:
447–457.
[14] Lopes AR, Kellam P, Das A, Dunn C, Kwan A, Turner J, et al. Bim-mediated
deletion of antigen-speciﬁc CD8 T cells in patients unable to control HBV
infection. J Clin Invest 2008;118:1835–1845.
[15] Kurts C, Robinson BW, Knolle PA. Cross-priming in health and disease. Nat
Rev Immunol 2010;10:403–414.
[16] Parish IA, Rao S, Smyth GK, Juelich T, Denyer GS, Davey GM, et al. The
molecular signature of CD8+ T cells undergoing deletional tolerance. Blood
2009;113:4575–4585.
[17] Limmer A, Ohl J, Kurts C, Ljunggren HG, Reiss Y, Groettrup M, et al. Efﬁcient
presentation of exogenous antigen by liver endothelial cells to CD8+ T cells
results in antigen-speciﬁc T-cell tolerance. Nat Med 2000;6:1348–1354.
[18] Diehl L, Schurich A, Grochtmann R, Hegenbarth S, Chen L, Knolle PA.
Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-
homolog 1-dependent CD8+ T cell tolerance. Hepatology 2008;47:296–305.2 vol. 57 j 718–719 719
